首页> 外文期刊>Neurosurgery quarterly. >Endoscopic Third Ventriculostomy in Patients With Vestibular Schwannoma and Hydrocephalus: A Clinical Trial
【24h】

Endoscopic Third Ventriculostomy in Patients With Vestibular Schwannoma and Hydrocephalus: A Clinical Trial

机译:前庭施瓦南瘤和脑积水患者的内窥镜第三节胃术:临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The purpose of this study was to elucidate the efficacy of endoscopic third ventriculostomy (ETV) and prognosis after treatment in patients with obstructive hydrocephalus due to vestibular schwannoma (VS). Patients and Methods: Between 2010 and 2012, 8 adults with VS underwent endoscopic procedures for the treatment of hydrocephalus at the authors' institution. Five patients were male individuals and 3 were female individuals. The patients had a mean age of 47.5 years and a follow-up period of 6 months. All cases had VS, with a mass effect on brainstem and associated obstructive hydrocephalus. ETV was performed using a rigid adult endoscope. Postoperatively, patients were followed up with physical examination and serial imaging studies (computed tomography scan and magnetic resonance imaging), and their cerebrospinal fluid flow through the stoma was evaluated. Nonparametric tests were applied for small number of patients, the Fisher exact test was applied for categorical variables, and the Mann-Whitney U test was applied for continuous variables. Results: The treatment outcome was successful in 5 patients (62.5%) and failed in 3 patients (1 patient died). A major complication in our cases was meningitis. There were 2 confirmed meningitis cases related to ETV in this group. During the follow-up period, the overall success rate was 62.5%. Conclusions: ETV is a safe procedure and an effective treatment option for hydrocephalus. Age and the analysis of underlying causes of hydrocephalus play important roles in the outcome prediction in patients with hydrocephalus who undergo ETV. Randomized clinical studies are needed to explore further the role of this treatment in patients having obstructive hydrocephalus associated with VS.
机译:目的:本研究的目的是阐明因前庭施瓦脉(VS)患者治疗患者治疗后的内镜第三脑膜术(ETV)和预后的疗效。患者及方法:2010年至2012年,2010年至2012年期间,8名成人与VS接受内窥镜手术治疗作者机构的脑积水。五名患者是男性个体,3名是女性个人。患者的年龄为47.5岁,随访时间为6个月。所有病例均具有与脑干和相关阻塞性脑积水的质量影响。使用刚性成人内窥镜进行ETV。术后,随访患者的物理检查和串行成像研究(计算断层摄影扫描和磁共振成像),并评估通过造口的脑脊液流动。非参数测试占少数患者,捕捞Fisher精确测试用于分类变量,并且施用Mann-Whitney U测试用于连续变量。结果:治疗结果在5名患者中成功(62.5%),并在3名患者失败(1例死亡)。在脑膜炎中的一个主要并发症是脑膜炎。在本集团中有2例确诊的脑膜炎病例。在随访期间,总成功率为62.5%。结论:ETV是一种安全的程序和脑积水有效的治疗选择。脑积水潜在原因的年龄和分析在接受etV的脑积水患者的结果预测中起重要作用。随机化的临床研究需要进一步探讨这种治疗在与与VS相关的阻塞性脑积水的患者中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号